Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.18
Ask:
0.25
Spread: 0.07 (38.889%)
Market Cap: £1.13m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

EPT Disclosure

22 Apr 2008 11:37

UBS AG (EPT)22 April 2008 FORM 38.5(b) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(b) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader UBS AG London BranchCompany dealt in Expro International Group PlcClass of relevant security to which the 10p Ordinarydealings being disclosed relate (Note 1)Date of dealing 21 APRIL 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) Long Short Number (%) Number (%)(1) Relevant securities 552,504 0.50% 0 0.00%(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal 552,504 0.50% 0 0.00% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal (c) Rights to subscribe (Note 2)Class of relevant security: Details 3. DEALINGS (Note 3) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 4) PURCHASE 300 1487 pence PURCHASE 300 1487 PURCHASE 300 1487 PURCHASE 3000 1490 SALE 600 1492 PURCHASE 374 1492 PURCHASE 300 1494 SALE 3 1495 PURCHASE 1050 1495 SALE 2100 1496 PURCHASE 125 1496 SALE 17 1496.5 SALE 904 1497 SALE 758 1497 SALE 523 1497 SALE 500 1497 SALE 362 1497 SALE 300 1497 SALE 200 1497 SALE 134 1497 SALE 20 1497 SALE 17 1497 SALE 17 1497 PURCHASE 17 1497 PURCHASE 71 1497 PURCHASE 75 1497 PURCHASE 132 1497 PURCHASE 271 1497 PURCHASE 316 1497 PURCHASE 350 1497 PURCHASE 362 1497 PURCHASE 367 1497 PURCHASE 398 1497 PURCHASE 162 1498 PURCHASE 232 1498 PURCHASE 341 1498 PURCHASE 371 1498 PURCHASE 395 1498 PURCHASE 458 1498 PURCHASE 536 1498 PURCHASE 782 1498 PURCHASE 800 1498 PURCHASE 925 1498 PURCHASE 1419 1498 SALE 965 1499 SALE 755 1499 SALE 700 1499 SALE 400 1499 SALE 356 1499 PURCHASE 357 1499 SALE 17 1499.5 PURCHASE 17 1499.5 PURCHASE 186 1500 PURCHASE 365 1500 PURCHASE 1000 1500 PURCHASE 1000 1500 PURCHASE 1250 1500 SALE 400 1501 SALE 239 1501 SALE 200 1501 SALE 170 1501 SALE 170 1501 SALE 100 1501 PURCHASE 351 1501 SALE 500 1502 SALE 322 1502 SALE 200 1502 SALE 200 1502 SALE 158 1502 SALE 157 1502 SALE 154 1502 SALE 100 1502 SALE 100 1502 SALE 7 1502 PURCHASE 271 1502 SALE 150 1503 SALE 137 1503 SALE 100 1503 SALE 100 1503 SALE 93 1503 PURCHASE 1300 1503 SALE 864 1507 SALE 300 1509 SALE 28 1509 PURCHASE 28 1509 TOTAL PURCHASES 20,654 TOTAL SALES 14,597 (b) Derivatives transactions (other than options)Product name, e.g Long/short (Note 5) Number of securities Price per unitCFD (Note 6) (Note 4) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/call purchasing, to which the European received peroption varying etc option etc. unit (Note relates 4) (Note 6) (ii) Exercising Product name, e.g. call Number of securities Exercise price per unitoption (Note 4) (d) Other dealings (including new securities) (Note 3) Nature of transaction Details Price per unit (if applicable)(Note 7) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 38.5(b) attached? (Note 8) NO Date of disclosure 22 APRIL 2008Contact name LOUISE ROBINSONTelephone number 020 7567 8762Name of offeree/offeror with which connected Halliburton CompanyNature of connection (Note 9) CONNECTED ADVISER Notes The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20267:00 amRNSNotice of AGM
2nd Jun 20267:00 amRNSFinal Results
7th Jan 20267:00 amRNSTrading Update
30th Sep 20257:00 amRNSUnaudited Interim Results
30th Jun 20257:00 amRNSResult of AGM - Replacement
26th Jun 202511:44 amRNSResult of AGM
3rd Jun 20253:00 pmRNSNotice of AGM & Posting of Annual Report
3rd Jun 20257:00 amRNSFinal Results
2nd May 20259:58 amRNSNotice of Results
3rd Apr 20257:00 amRNS-RASU+GSV Summit, Launch of Titanic VR & ENGAGE 4.0
10th Feb 20257:00 amRNS-RENGAGE XR attending Leap 2025 with PwC Middle East
22nd Jan 20257:00 amRNS-RLaunch of Education Offering at Bett 2025
6th Jan 20257:00 amRNSPre-Close Trading Update
26th Sep 20243:51 pmRNSHolding(s) in Company
26th Sep 20243:50 pmRNSHolding(s) in Company
19th Sep 20247:00 amRNSUnaudited Interim Results
9th Aug 20247:00 amRNSAppointment of Sole Broker
6th Aug 20247:00 amRNSPre-Close Trading Update and Notice of Results
30th Jul 20245:32 pmRNSHolding(s) in Company
10th Jul 20248:59 amRNSHolding(s) in Company
27th Jun 20244:11 pmRNSHolding(s) in Company
27th Jun 20243:35 pmRNSResult of AGM
28th May 20247:22 amRNSNotice of AGM & Posting of Annual Report
28th May 20247:00 amRNSBoard and Committee Changes
23rd Apr 202412:53 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSFinal Results
28th Mar 20247:00 amRNSNotice of Results & Investor Presentation
13th Mar 20247:00 amRNSLaunch of School of AI
26th Feb 20247:00 amRNSTrading Update
23rd Feb 20247:00 amRNSHolding(s) in Company
20th Feb 20247:00 amRNSMajor Contract Wins
19th Dec 20237:00 amRNSTrading Update
8th Dec 20237:00 amRNSBoard Change
11th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSNotice of Investor Presentation
3rd Aug 20237:00 amRNSGrant of Options
1st Aug 20237:00 amRNSPre-Close Trading Update and Notice of Results
29th Jun 20232:23 pmRNSResult of AGM
7th Jun 20237:00 amRNSNotice of AGM
1st Jun 20237:00 amRNSLaunch of Lenovo’s new VR headset
23rd May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSInvestor Presentation
27th Apr 20237:00 amRNSTrading Update & Notice of Results
31st Mar 20237:00 amRNSFatboy Slim concert takes place in ENGAGE Link
21st Mar 20237:00 amRNSCancellation of Admission to Euronext Growth
17th Mar 20237:00 amRNSFatboy Slim set to perform in ENGAGE
8th Mar 20231:05 pmRNSTR-1: Notification of major holdings
7th Mar 20235:30 pmRNSTR-1: Notification of major holdings
7th Mar 20232:19 pmRNSTR-1: Notification of major holdings
6th Mar 20234:50 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.